(Q44707465)

5 December 2017

title

Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial (English)

1 reference

adaptive radiation therapy

5 December 2017

main subject

phase II clinical trial

0 references

0 references

1 reference

Gilles Calais

1

1 reference

5 December 2017

Etienne Bardet

2

1 reference

5 December 2017

Christian Sire

3

1 reference

5 December 2017

Marc Alfonsi

4

1 reference

5 December 2017

Jean Bourhis

5

1 reference

5 December 2017

Béatrix Rhein

6

1 reference

5 December 2017

Jacques Tortochaux

7

1 reference

5 December 2017

Yooye Tao Kong Man

8

1 reference

5 December 2017

Hugues Auvray

9

1 reference

5 December 2017

Pascal Garaud

10

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

International Journal of Radiation Oncology Biology Physics

5 December 2017

published in

1 reference

5 December 2017

volume

58

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

161-166

1 reference

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901370-1

7 January 2021

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901370-1

7 January 2021

Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901370-1

7 January 2021

A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901370-1

7 January 2021

Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901370-1

7 January 2021

Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901370-1

7 January 2021

Relationships between the structure of taxol analogs and their antimitotic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901370-1

7 January 2021

Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901370-1

7 January 2021

Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901370-1

7 January 2021

Phase I study of docetaxel with concomitant thoracic radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901370-1

7 January 2021

Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901370-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901370-1

1 reference

7 January 2021

Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901370-1

7 January 2021

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901370-1

7 January 2021

A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901370-1

7 January 2021

10.1016/S0360-3016(03)01370-1

Identifiers

DOI

1 reference

5 December 2017

1 reference